Mulsevo (semuloparin sodium)
- Region
- 🇪🇺 EU
- Active substance
- semuloparin sodium
- Company
- Sanofi-aventis groupe
- Status
- Application withdrawn
- Application
- EMEA/H/C/002516
- Official record
- www.ema.europa.eu
Indication
prevention of venous thromboembolism
Regulatory milestones
No milestones recorded in the last year.
Follow Mulsevo
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.